Skip to main content
. 2014 Mar 18;23(9):765–772. doi: 10.1136/bmjqs-2013-002572

Table 1 .

Incidents presented according to the main defence (as in figure 1) breached

Defence Number of reports
Administration only in designated centres 0
Only those on local register can prescribe, dispense, issue, check or administer intrathecal (IT) chemotherapy 0
IT chemotherapy on separate prescription with accompanying checklist and audit trail 1
Intravenous (IV) and IT chemotherapy separated in time 15
 1. Administered at separate times—IV then IT 6
 2. Signature to confirm all IV chemotherapy for that day given, before IT released to the doctor who will administer it 9
IV and IT chemotherapy separated in location 7
 1. Separate storage in pharmacy and ward areas, with IT doses in a dedicated locked fridge 5
 2. Separate storage in pharmacy and ward areas, with IT doses in a dedicated locked fridge 5
 3. Separate transport of IT in distinctive container 1
 4. Administration in separate clinical areas 1
IV and IT chemotherapy differentiated in appearance 6
 1. IV vinca alkaloids for adults and adolescents prepared in minibags, not syringes 1
 2. Labelling of medication with route of administration printed in bold ‘for intrathecal use only’ and ‘for intravenous use only’ 5
Under normal circumstances, administered during working hours only 0
Administration checks 0
Other 6
TOTAL 35 

Bold numbers represent main categories; italic numbers represent sub-categories of these.